增殖性玻璃体视网膜病变：重新评估
Proliferative Vitreoretinopathy: A Reappraisal.
作者信息
Carpineto Paolo, Licata Arturo Maria, Ciancaglini Marco
机构信息
Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.
Department of Clinical Medicine, Public Health, Life and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
出版信息
J Clin Med. 2023 Aug 14;12(16):5287. doi: 10.3390/jcm12165287.
Proliferative vitreoretinopathy (PVR) remains the main cause of failure after retinal detachment (RD) surgery. Despite the development of modern technologies and sophisticated techniques for the management of RD, the growth of fibrocellular membranes within the vitreous cavity and on both sides of the retinal surface, as well as intraretinal fibrosis, can compromise surgical outcomes. Since 1983, when the term PVR was coined by the Retina Society, a lot of knowledge has been obtained about the physiopathology and risk factors of PVR, but, despite the proposal of a lot of therapeutic challenges, surgical skills seem to be the only effective way to manage PVR complications.
增殖性玻璃体视网膜病变（PVR）仍然是视网膜脱离（RD）手术后手术失败的主要原因。尽管在RD的治疗方面已经发展出现代技术和复杂技巧，但玻璃体腔内以及视网膜表面两侧纤维细胞膜的生长，以及视网膜内纤维化，仍会影响手术效果。自1983年视网膜协会提出“PVR”这一术语以来，人们已经获得了许多关于PVR的病理生理学和危险因素的知识，但是，尽管提出了许多治疗挑战，手术技巧似乎仍是处理PVR并发症的唯一有效方法。
Zotero 插件